Skip to main content

MacDonald James J.'s Form 4 filing

Sana Biotechnology, Inc.SANA · filed Feb 23, 2022

Accession no.
0001562180-22-001784
Filed
Feb 23, 2022
Trade date
Nov 15, 2021-Feb 18, 2022
Filing delay
100 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market sales total $2.09K. It was filed 100 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
MacDonald James J.CIK 0001830054Officer (EVP & General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 15, 2021Common StockAGrant or awardAcquired+1,000$18.23F2+$18,230429,750Direct
Feb 18, 2022Common StockSSaleDisposed−333$6.28−$2,091.24429,417Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2021.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)